Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
141.17
Aug 07 • 3:59 PM ET Dollar change+1.87 Percentage change(1.34%)
Aftermarket Close
140.85
Aftermarket • 7:42 PM ET Dollar change-0.32 Percentage change(-0.23%)
Aug 06, 10:35 AMBTIG and JPMorgan downgrade Insulet to Neutral on weaker U.S. Omnipod trends as JPMorgan cuts target to $152 from $275
Index
S&P 500
Market Cap
9.79B
Enterprise Value
10.20B
Income
375.30M
Sales
3.05B
Book/sh
20.51
Cash/sh
7.71
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
5400
IPO
May 15, 2007
P/E
27.99
Forward P/E
18.26
PEG
0.78
P/S
3.21
P/B
6.88
P/C
18.30
P/FCF
33.34
EV/EBITDA
15.95
EV/Sales
3.34
Quick Ratio
1.80
Current Ratio
2.45
Debt/Eq
0.67
LT Debt/Eq
0.65
Option/Short
Yes / Yes
EPS (ttm)
5.04
EPS next Y
7.73
EPS next Q
1.60
EPS this Y
30.96%
EPS next Y
18.80%
EPS next 5Y
23.41%
EPS past 3/5Y
275.33% 102.14%
Sales past 3/5Y
27.54% 24.53%
EPS Y/Y TTM
59.39%
Sales Y/Y TTM
29.41%
EPS Q/Q
234.76%
Sales Q/Q
23.51%
Insider Own
0.43%
Insider Trans
4.25%
Inst Own
103.99%
Inst Trans
-1.42%
ROA
11.31%
ROE
26.02%
ROIC
15.96%
Gross Margin
72.16%
Oper. Margin
16.88%
Profit Margin
12.29%
SMA20
-11.91%
SMA50
-8.90%
SMA200
-38.07%
Trades
Shs Outstand
69.35M
Shs Float
69.05M
52W High
354.88 -60.22%
52W Low
126.40 11.69%
Volatility
5.65% 4.08%
ATR (14)
8.77
RSI (14)
37.63
Beta
1.07
Rel Volume
0.98
Avg Volume
1.63M
Volume
1,591,344
Perf Week
-14.62%
Perf Month
-10.82%
Perf Quarter
-11.99%
Perf Half Y
-41.94%
Perf YTD
-50.33%
Perf Year
-53.49%
Perf 3Y
-45.88%
Perf 5Y
-48.76%
Perf 10Y
227.09%
Prev Close
139.30
Price
141.17
Change %
1.34%
Date Action Analyst Rating Change Price Target Change
Aug-06-26Downgrade Wells Fargo Overweight → Equal Weight $144
Aug-06-26Downgrade Truist Buy → Hold $153
Aug-06-26Downgrade Leerink Partners Outperform → Market Perform $145
Aug-06-26Downgrade JP Morgan Overweight → Neutral $152
Aug-06-26Downgrade BTIG Research Buy → Neutral
Aug-05-26Downgrade Oppenheimer Outperform → Perform
Jul-28-26Resumed UBS Neutral $174
Jun-23-26Initiated Deutsche Bank Buy $190
May-20-26Resumed William Blair Outperform
Apr-24-26Downgrade Rothschild & Co Redburn Buy → Neutral $220
Aug-06-26 09:48AM
08:50AM
Aug-05-26 06:42PM
04:54PM
04:30PM
03:03PM Loading…
03:03PM
12:17PM
10:45AM
07:09AM
07:00AM
Jul-29-26 08:27AM
Jul-20-26 12:43PM
Jul-15-26 04:59AM
Jul-14-26 03:00AM
Jul-13-26 05:14PM
08:08AM Loading…
Jul-10-26 08:08AM
Jul-08-26 05:38PM
Jul-07-26 09:22AM
07:10AM
Jul-01-26 07:00AM
Jun-25-26 07:00AM
Jun-09-26 04:30PM
Jun-06-26 07:00AM
Jun-05-26 06:25AM
Jun-04-26 07:00AM
Jun-03-26 07:00AM
Jun-01-26 03:42AM
May-28-26 11:28AM
08:03AM
May-27-26 04:30PM
04:05PM Loading…
04:05PM
07:29AM
07:29AM
May-26-26 04:05PM
06:15AM
May-19-26 11:52AM
May-13-26 04:30PM
May-12-26 09:56AM
May-06-26 01:00PM
07:33AM
07:16AM
07:00AM
May-05-26 07:00AM
May-04-26 07:00AM
Apr-28-26 07:00AM
Apr-24-26 09:44AM
Apr-23-26 11:54AM
Apr-01-26 07:00AM
Mar-31-26 03:09PM
06:30AM
Mar-13-26 04:45PM
01:08PM
11:18AM
07:31AM
Mar-12-26 04:05PM
Mar-11-26 04:01PM
05:26AM
Mar-10-26 07:00AM
Mar-03-26 09:10AM
Feb-26-26 10:29PM
Feb-24-26 11:33AM
06:25AM
Feb-23-26 03:46PM
Feb-20-26 05:00AM
Feb-19-26 08:09AM
12:31AM
Feb-18-26 04:33PM
02:00PM
01:57PM
12:26PM
11:40AM
09:36AM
09:30AM
08:15AM
07:37AM
07:27AM
07:07AM
07:00AM
Feb-17-26 05:35PM
Feb-16-26 10:04PM
Feb-15-26 06:53AM
Feb-13-26 04:36PM
11:26AM
Feb-12-26 09:15AM
Feb-11-26 10:00AM
Feb-10-26 07:40AM
Feb-05-26 07:00AM
Feb-02-26 07:50PM
Jan-30-26 02:31PM
Jan-29-26 09:08PM
Jan-27-26 09:37AM
08:00AM
Jan-26-26 09:45AM
Jan-23-26 07:30PM
Jan-22-26 08:59PM
08:24AM
Jan-21-26 05:00AM
Jan-20-26 07:20PM
Jan-15-26 05:26AM
Jan-14-26 12:53PM
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
CEOMs. Ashley A. McEvoy
Executive VP & CFOMs. Flavia H. Pease
Executive VP & COOMr. Eric Benjamin
Senior VP & General CounselMr. John Wodick Kapples J.D.
Senior Vice President of Global OperationsMr. Prem Singh
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STONESIFER TIMOTHY C.DirectorJun 03 '26Buy143.512,790400,3939,041Jun 04 04:25 PM
BORIO LUCIANADirectorJun 03 '26Sale143.2741859,8874,329Jun 04 04:23 PM
WEATHERMAN ELIZABETH HDirectorJun 03 '26Buy144.203,450497,49010,352Jun 03 04:19 PM
BORIO LUCIANADirectorJun 03 '26Proposed Sale143.2641859,885Jun 03 03:07 PM
MINOGUE MICHAEL RDirectorFeb 25 '26Buy246.232,030499,84717,483Feb 26 07:05 AM
McEvoy AshleyPresident and CEOFeb 20 '26Buy239.354,3001,029,20513,916Feb 23 08:14 AM
Frederick Wayne A.I.DirectorDec 15 '25Sale293.091,851542,5102,158Dec 16 04:04 PM
Frederick Wayne A.I.DirectorDec 15 '25Proposed Sale293.091,851542,500Dec 15 03:03 PM
STONESIFER TIMOTHY C.DirectorDec 05 '25Buy311.73962299,8844,591Dec 08 04:02 PM
Manea DanFormer OfficerNov 26 '25Proposed Sale326.644,4751,461,716Nov 26 04:31 PM
Manea DanFormer OfficerNov 24 '25Proposed Sale340.952,306786,228Nov 24 04:06 PM
Manea DanFormer OfficerSep 16 '25Proposed Sale337.731,347454,920Sep 16 01:21 PM
Singh PremSVP, Global OperationsSep 08 '25Sale347.49687238,7263,456Sep 09 04:19 PM
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Option Exercise241.10797192,1604,687Sep 09 04:16 PM
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Sale348.81797278,0023,890Sep 09 04:16 PM
Cousin LaetitiaOfficerSep 08 '25Proposed Sale348.81797278,000Sep 08 02:07 PM
Singh PremOfficerSep 08 '25Proposed Sale347.48687238,718Sep 08 01:31 PM
Benjamin EricEVP, CPXOAug 21 '25Sale332.234,2631,416,29616,736Aug 22 04:16 PM
Benjamin EricOfficerAug 21 '25Proposed Sale332.234,2631,416,296Aug 21 10:21 AM